Skip to main content
Clinical Trials/NCT03026452
NCT03026452
Unknown
Phase 1

Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer

First Affiliated Hospital of Zhejiang University1 site in 1 country400 target enrollmentJanuary 2013
ConditionsLiver Cancer

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Liver Cancer
Sponsor
First Affiliated Hospital of Zhejiang University
Enrollment
400
Locations
1
Primary Endpoint
Tumor size assessed by MRI
Last Updated
7 years ago

Overview

Brief Summary

To evaluate the safety and efficacy of ultrasonography (US) -guided radiofrequency ablation for liver tumors, the investigators used preoperative and postoperative US/CEUS(contrast-enhanced ultrasonography)/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
December 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
First Affiliated Hospital of Zhejiang University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with small hepatocellular carcinoma (single or multiple nodules of less than 3 cm in diameter), Patients with Child-Pugh A/B, Patients with PLT(platelet count) ≥ 50\*10e9/L and PT(prothrombin time) ≤ 20s.

Exclusion Criteria

  • Patients with blood coagulation dysfunction, ChildPugh score≥3, severe cardiopulmonary disease, intolerant anesthesia and upper gastrointestinal bleeding in shock.

Outcomes

Primary Outcomes

Tumor size assessed by MRI

Time Frame: through study completion, an average of 2 year

Tumor size was estimated by MRI.

Secondary Outcomes

  • Carcinoembryonic Antigen (CEA) level assessed by ELISA(through study completion, an average of 2 year)
  • Alpha Fetoprotein (AFP) level assessed by ELISA(through study completion, an average of 2 year)

Study Sites (1)

Loading locations...

Similar Trials